Pulsalys

Lyophitech is a manufacturer of innovative freeze-drying equipment tailored for the pharmaceutical sector and other industries such as food and microbiology. The company specializes in developing patented technologies that streamline and enhance freeze-drying processes, enabling clients to complete drying cycles more efficiently. By focusing on reducing operating time and costs, Lyophitech's equipment supports continuous operation and addresses common challenges associated with freeze-drying. With applications extending to probiotics and plant extracts, the company positions itself as a leader in advancing freeze-drying methodologies across various sectors.

Mecaware specializes in battery recycling services, focusing on recovering critical metals and rare earth elements. Utilizing a patented dynamic combinatorial chemistry process, the company operates in a closed-loop manner with minimal energy requirements and no effluent waste, enhancing resource efficiency and reducing environmental impact for various industries.

Lys Therapeutics is a biotechnology company focused on developing therapies for patients with neurovascular and neurodegenerative disorders. The company is notable for its lead drug, Glunozumab, a monoclonal antibody that employs a novel mechanism of action. This drug hyperactivates both vascular and neuronal NMDA receptors, leading to off-target toxicity that can disrupt the blood-brain and blood-spinal cord barriers, resulting in neuronal excitotoxicity associated with conditions such as stroke and multiple sclerosis. Lys Therapeutics aims to address neuroinflammation and its effects on neurodegeneration through innovative biotherapies.